Top

Published in:

01-09-2019 | Original Article

Hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal malignancies using new hybrid CO₂ system: preliminary experience in referral center

Authors: Stefano Cianci, Carlo Abatini, Anna Fagotti, Benito Chiofalo, Alessandro Tropea, Antonio Biondi, Giovanni Scambia, Fabio Pacelli

Published in: Updates in Surgery | Issue 3/2019

Abstract

The most frequent peritoneal surface malignancies originate principally by gastric cancer, colorectal cancer and ovarian cancer. Apart from the origin, peritoneal carcinosis (PC) is considered a negative prognostic factor. The hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in the treatment of peritoneal malignancies is considered an attractive method to deliver chemotherapy with enhanced effect directly at the tumor site. The use of such loco-regional approach has proved to improve prognosis of peritoneal carcinomatosis from different origins. Recently, new devices are suitable for loco-regional intraperitoneal chemotherapy as Peritoneal Recirculation System (PRS-1.0 Combat) with CO₂ technology. This is a retrospective study with the aim to assess the perioperative outcomes using PRS. Seventeen patients were enrolled affected by colorectal or ovarian cancer. Complete cytoreduction (RT = 0) was achieved for all cases. Median operative time was 420 min (range: 335–665) and median drugs dose used for HIPEC was 137 mg/m2 (115–756). Median EBL was 200 ml (range 50–1000). Median post-operative hospital stay was 9 days (range: 4–24). Treatment-related early complications were recorded in 8 (47.0%) cases and were G1–G2 Major complications occurred in two (11.7%) cases. Considering our aim to test the PRS in different cases and in different pathologies, the results confirmed that the technique is feasible with good perioperative outcomes.

Caruso S, Rugolo S, Bandiera S et al (2007) Clitoral blood flow changes after surgery for stress urinary incontinence: pilot study on TVT versus TOT procedures. Urology 70:554–557. https://doi.org/10.1016/j.urology.2007.04.045 CrossRefPubMed

Caruso S, Cianci S, Vitale SG et al (2017) Effects of ultralow topical estriol dose on vaginal health and quality of life in postmenopausal women who underwent surgical treatment for pelvic organ prolapse. Menopause 24:900–907. https://doi.org/10.1097/GME.0000000000000851 CrossRefPubMed

Cicinelli E, Pinto V, Tinelli R et al (2007) Rapid endometrial preparation for hysteroscopic surgery with oral desogestrel plus vaginal raloxifene: a prospective, randomized pilot study. Fertil Steril 88(3):698–701. https://doi.org/10.1016/j.fertnstert.2006.11.151 CrossRefPubMed

Vitale SG, Sapia F, Rapisarda AMC et al (2017) Hysteroscopic morcellation of submucous myomas: a systematic review. Biomed Res Int 2017:6848250CrossRefPubMedPubMedCentral

Sturlese E, Triolo O, Grasso R et al (2017) Thromboembolism prophylaxis in laparoscopic surgery for gynecologic benign diseases. Results of a single center experience in 922 procedures. Ann Ital Chir 88:342–347PubMed

Di Spiezio Sardo A, da Cunha Vieira M, Laganà AS et al (2017) combined systemic and hysteroscopic intra-amniotic injection of methotrexate associated with hysteroscopic resection for cervical pregnancy: a cutting-edge approach for an uncommon condition. Eur J Med 49:66–68. https://doi.org/10.5152/eurasianjmed.2017.16215 CrossRef

Butticè S, Laganà AS, Mucciardi G et al (2016) Different patterns of pelvic ureteral endometriosis. What is the best treatment? Results of a retrospective analysis. Arch Ital Urol Androl 88(4):266–269. https://doi.org/10.4081/aiua.2016.4.266 CrossRefPubMed

Laganà AS, Vitale SG, Muscia V et al (2017) Endometrial preparation with dienogest before hysteroscopic surgery: a systematic review. Arch Gynecol Obstet 295:661–667. https://doi.org/10.1007/s00404-016-4244-1 CrossRefPubMed

Bellia A, Vitale SG, Laganà AS et al (2016) Feasibility and surgical outcomes of conventional and robot-assisted laparoscopy for early-stage ovarian cancer: a retrospective, multicenter analysis. Arch Gynecol Obstet 294:615–622. https://doi.org/10.1007/s00404-016-4087-9 CrossRefPubMed

10.

Vitale SG, Rossetti D, Tropea A et al (2017) Fertility sparing surgery for stage IA type I and G2 endometrial cancer in reproductive-aged patients: evidence-based approach and future perspectives. Updates Surg 69:29–34CrossRefPubMed

11.

Cignini P, Vitale SG, Laganà AS et al (2017) Preoperative work-up for definition of lymph node risk involvement in early stage endometrial cancer: 5-year follow-up. Updates Surg 69:75–82. https://doi.org/10.1007/s13304-017-0418-z CrossRefPubMed

12.

Chiofalo B, Palmara V, Laganà AS et al (2017) Fertility sparing strategies in patients affected by placental site trophoblastic tumor. Curr Treat Options Oncol 18:58CrossRefPubMed

13.

VITALE SG, La Rosa VL, Rapisarda AMC, LAGANA’ AS (2018) Fertility preservation in women with gynaecologic cancer: the impact on quality of life and psychological well-being. Hum Fertil 21:35–38. https://doi.org/10.1080/14647273.2017.1339365 CrossRef

14.

Laganà AS, La Rosa VL, Rapisarda AMC et al (2017) Psychological impact of fertility preservation techniques in women with gynaecological cancer. Ecancermedicalscience 11:ed62. https://doi.org/10.3332/ecancer.2017.ed62 CrossRefPubMedPubMedCentral

15.

Rossetti D, Vitale SG, Tropea A et al (2017) New procedures for the identification of sentinel lymph node: shaping the horizon of future management in early stage uterine cervical cancer. Updates Surg 69:383–388. https://doi.org/10.1007/s13304-017-0456-6 CrossRefPubMed

16.

Tozzi R, Giannice R, Cianci S et al (2015) Neo-adjuvant chemotherapy does not increase the rate of complete resection and does not significantly reduce the morbidity of Visceral-Peritoneal Debulking (VPD) in patients with stage IIIC-IV ovarian cancer. Gynecol Oncol 138:252–258. https://doi.org/10.1016/j.ygyno.2015.05.010 CrossRefPubMed

17.

Vitale SG, Marilli I, Lodato M et al (2013) The role of cytoreductive surgery in advanced-stage ovarian cancer: a systematic review. Updates Surg. 65:265–270CrossRefPubMed

18.

Montori G, Coccolini F, Fugazzola P et al (2018) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in ovarian and gastrointestinal peritoneal carcinomatosis: results from a 7-year experience. J Gastrointest Oncol 9:241–253. https://doi.org/10.21037/jgo.2017.12.04 CrossRefPubMedPubMedCentral

19.

Cosentino F, Vizzielli G, Turco LC et al (2018) Near-infrared imaging with indocyanine green for detection of endometriosis lesions (Gre-Endo Trial): a pilot study. J Minim Invasive Gynecol. https://doi.org/10.1016/j.jmig.2018.02.023 CrossRefPubMed

20.

Caruso S, Panella MM, Cianci S et al (2011) TOT does not affect the urethral sphincter innervation: a pilot study. Int Urogynecol J 22:739–742. https://doi.org/10.1007/s00192-011-1364-9 CrossRefPubMed

21.

Lagana AS, Vitale SG, De Dominici R et al (2016) Fertility outcome after laparoscopic salpingostomy or salpingectomy for tubal ectopic pregnancy A 12 years retrospective cohort study. Ann Ital Chir 87:461–465PubMed

22.

Matarazzo MG, Cianci S, Rampello L et al (2013) Urethral sphincter innervation and clitoral blood flow after the transobturator (TOT) approach. Int Urogynecol J 24:621–625. https://doi.org/10.1007/s00192-012-1891-z CrossRefPubMed

23.

Rossitto C, Cianci S, Gueli Alletti S et al (2017) Laparoscopic, minilaparoscopic, single-port and percutaneous hysterectomy: comparison of perioperative outcomes of minimally invasive approaches in gynecologic surgery. Eur J Obstet Gynecol Reprod Biol 216:125–129. https://doi.org/10.1016/j.ejogrb.2017.07.026 CrossRefPubMed

24.

Vitale SG, Laganà AS, Noventa M et al (2018) Transvaginal bilateral sacrospinous fixation after second recurrence of vaginal vault prolapse: efficacy and impact on quality of life and sexuality. Biomed Res Int 2018:1–6. https://doi.org/10.1155/2018/5727165 CrossRef

25.

Vitale SG, Caruso S, Rapisarda AMC et al (2016) Biocompatible porcine dermis graft to treat severe cystocele: impact on quality of life and sexuality. Arch Gynecol Obstet 293:125–131. https://doi.org/10.1007/s00404-015-3820-0 CrossRefPubMed

26.

Laganà AS, Vitale SG, Trovato MA et al (2016) Full-thickness excision versus shaving by laparoscopy for intestinal deep infiltrating endometriosis: rationale and potential treatment options. Biomed Res Int 2016:3617179CrossRefPubMedPubMedCentral

27.

Gueli Alletti S, Rossitto C, Cianci S et al (2018) The Senhance™ surgical robotic system (“Senhance”) for total hysterectomy in obese patients: a pilot study. J Robot Surg 12:229–234. https://doi.org/10.1007/s11701-017-0718-9 CrossRefPubMed

28.

Gueli Alletti S, Perrone E, Cianci S et al (2018) 3 mm Senhance robotic hysterectomy: a step towards future perspectives. J Robot Surg. https://doi.org/10.1007/s11701-018-0778-5 CrossRefPubMed

29.

Rossitto C, Gueli Alletti S, Rotolo S et al (2016) Total laparoscopic hysterectomy using a percutaneous surgical system: a pilot study towards scarless surgery. Eur J Obstet Gynecol Reprod Biol 203:132–135. https://doi.org/10.1016/j.ejogrb.2016.05.007 CrossRefPubMed

30.

Rapisarda AMC, Cianci A, Caruso S et al (2018) Benign multicystic mesothelioma and peritoneal inclusion cysts: are they the same clinical and histopathological entities? A systematic review to find an evidence-based management. Arch Gynecol Obstet 297:1353–1375. https://doi.org/10.1007/s00404-018-4728-2 CrossRefPubMed

31.

Rossitto C, Gueli Alletti S, Cianci S et al (2017) Reply. J Minim Invasive Gynecol 24:683–684. https://doi.org/10.1016/j.jmig.2017.02.001 CrossRefPubMed

32.

Fagotti A, Costantini B, Gallotta V et al (2015) Minimally invasive secondary cytoreduction plus hipec versus open surgery plus HIPEC in isolated relapse from ovarian cancer: a retrospective cohort study on perioperative outcomes. J Minim Invasive Gynecol 22:428–432. https://doi.org/10.1016/j.jmig.2014.11.008 CrossRefPubMed

33.

Gueli Alletti S, Rossitto C, Cianci S, Scambia G (2016) Telelap ALF-X total hysterectomy for early stage endometrial cancer: new frontier of robotic gynecological surgery. Gynecol Oncol 140:575–576. https://doi.org/10.1016/j.ygyno.2016.01.018 CrossRefPubMed

34.

Gueli Alletti S, Rossitto C, Cianci S et al (2016) Telelap ALF-X vs standard laparoscopy for the treatment of early-stage endometrial cancer: a single-institution retrospective cohort study. J Minim Invasive Gynecol 23:378–383. https://doi.org/10.1016/j.jmig.2015.11.006 CrossRefPubMed

35.

Gueli Alletti S, Rossitto C, Perrone E et al (2017) Needleoscopic conservative staging of borderline ovarian tumor. J Minim Invasive Gynecol 24:529–530. https://doi.org/10.1016/j.jmig.2016.10.009 CrossRefPubMed

36.

Gallotta V, Conte C, Giudice MT et al (2017) Secondary laparoscopic cytoreduction in recurrent ovarian cancer: a large, single-institution experience. J Minim Invasive Gynecol 25:644–650CrossRefPubMed

37.

Gueli Alletti S, Vizzielli G, Lafuenti L et al (2018) Single-institution propensity-matched study to evaluate the psychological effect of minimally invasive interval debulking surgery versus standard laparotomic treatment: from body to mind and back. J Minim Invasive Gynecol 25:816–822CrossRefPubMed

38.

Golse N, Bakrin N, Passot G et al (2012) Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: postoperative and long-term results. J Surg Oncol 106:197–203. https://doi.org/10.1002/jso.23062 CrossRefPubMed

39.

Petrillo M, De Iaco P, Cianci S et al (2016) Long-term survival for platinum-sensitive recurrent ovarian cancer patients treated with secondary cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol 23:1660–1665. https://doi.org/10.1245/s10434-015-5050-x CrossRefPubMed

40.

Vassos N, Förtsch T, Aladashvili A et al (2016) Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis. World J Surg Oncol 14:42. https://doi.org/10.1186/s12957-016-0804-x CrossRefPubMedPubMedCentral

41.

van Driel WJ, Koole SN, Sikorska K et al (2018) Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med 378:230–240. https://doi.org/10.1056/NEJMoa1708618 CrossRefPubMed

42.

Alyami M, Gagniere J, Sgarbura O et al (2017) Multicentric initial experience with the use of the pressurized intraperitoneal aerosol chemotherapy (PIPAC) in the management of unresectable peritoneal carcinomatosis. Eur J Surg Oncol 43:2178–2183. https://doi.org/10.1016/j.ejso.2017.09.010 CrossRefPubMed

43.

Khosrawipour T, Khosrawipour V, Giger-Pabst U (2017) Pressurized intra peritoneal aerosol chemotherapy in patients suffering from peritoneal carcinomatosis of pancreatic adenocarcinoma. PLoS One 12:e0186709. https://doi.org/10.1371/journal.pone.0186709 CrossRefPubMedPubMedCentral

44.

Sánchez-García S, Villarejo-Campos P, Padilla-Valverde D et al (2016) Intraperitoneal chemotherapy hyperthermia (HIPEC) for peritoneal carcinomatosis of ovarian cancer origin by fluid and CO2recirculation using the closed abdomen technique (PRS-1.0 Combat): a clinical pilot study. Int J Hyperth 32:488–495. https://doi.org/10.3109/02656736.2016.1152515 CrossRef

45.

Padilla-Valverde D, Sanchez-Garcia S, García-Santos E et al (2017) Usefulness of thermographic analysis to control temperature homogeneity in the development and implementation of a closed recirculating CO2chemohyperthermia model. Int J Hyperth 33:220–226. https://doi.org/10.1080/02656736.2016.1237679 CrossRef

46.

Sánchez-García S, Padilla-Valverde D, Villarejo-Campos P et al (2017) Hyperthermic chemotherapy intra-abdominal laparoscopic approach: development of a laparoscopic model using CO₂ recirculation system and clinical translation in peritoneal carcinomatosis. Int J Hyperth 33:684–689. https://doi.org/10.1080/02656736.2017.1302100 CrossRef

47.

Fagotti A, Ferrandina G, Fanfani F et al (2006) A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study. Ann Surg Oncol 13:1156–1161. https://doi.org/10.1245/ASO.2006.08.021 CrossRefPubMed

48.

Sugarbaker PH, Chang D (1999) Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 6:727–731CrossRef

49.

Sugarbaker PH (1996) Peritoneal carcinomatosis: principles of management. Springer, BostonCrossRef

50.

Dindo D, Demartines N, Clavien P-A (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedPubMedCentral

51.

Chiva LM, Gonzalez-Martin A (2015) A critical appraisal of hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of advanced and recurrent ovarian cancer. Gynecol Oncol 136:130–135. https://doi.org/10.1016/j.ygyno.2014.11.072 CrossRef

52.

Tentes AAK, Spiliotis ID, Korakianitis OS et al (2011) Adjuvant perioperative intraperitoneal chemotherapy in locally advanced colorectal carcinoma: preliminary results. ISRN Surg 2011:529876. https://doi.org/10.5402/2011/529876 CrossRefPubMedPubMedCentral

53.

Sammartino P, Sibio S, Biacchi D et al (2012) Prevention of peritoneal metastases from colon cancer in high-risk patients: preliminary results of surgery plus prophylactic HIPEC. Gastroenterol Res Pract 2012:141585. https://doi.org/10.1155/2012/141585 CrossRefPubMedPubMedCentral

54.

Sammartino P, Sibio S, Biacchi D et al (2014) Long-term results after proactive management for locoregional control in patients with colonic cancer at high risk of peritoneal metastases. Int J Colorectal Dis 29:1081–1089. https://doi.org/10.1007/s00384-014-1929-4 CrossRefPubMed

55.

Baratti D, Kusamura S, Iusco D et al (2017) Hyperthermic intraperitoneal chemotherapy (HIPEC) at the time of primary curative surgery in patients with colorectal cancer at high risk for metachronous peritoneal metastases. Ann Surg Oncol 24:167–175. https://doi.org/10.1245/s10434-016-5488-5 CrossRefPubMed

56.

Glehen O, Gilly FN, Arvieux C et al (2010) Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol 17:2370–2377. https://doi.org/10.1245/s10434-010-1039-7 CrossRefPubMed

57.

Cianci S, Vizzielli G, Fagotti A et al (2018) A novel HIPEC technique using hybrid CO₂ recirculation system: intra-abdominal diffusion test in a porcine model. Updates Surg. https://doi.org/10.1007/s13304-018-0557-x CrossRefPubMed

58.

Issels RD (2008) Hyperthermia adds to chemotherapy. Eur J Cancer 44:2546–2554. https://doi.org/10.1016/j.ejca.2008.07.038 CrossRefPubMed

Title: Hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal malignancies using new hybrid CO2 system: preliminary experience in referral center
Authors: Stefano Cianci
Carlo Abatini
Anna Fagotti
Benito Chiofalo
Alessandro Tropea
Antonio Biondi
Giovanni Scambia
Fabio Pacelli
Publication date: 01-09-2019
Publisher: Springer International Publishing
Published in: Updates in Surgery / Issue 3/2019
Print ISSN: 2038-131X
Electronic ISSN: 2038-3312
DOI: https://doi.org/10.1007/s13304-018-0578-5

At a glance: The STEP trials

Springer Medicine

Hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal malignancies using new hybrid CO₂ system: preliminary experience in referral center

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2019

Esophagojejunal anastomotic fistula: a major issue after radical total gastrectomy

Gastric cancer surgery: clinical outcomes and prognosis are influenced by perioperative blood transfusions

Vacuum-assisted management of surgical site infections after liver transplantation: 15-year experience in a tertiary hepatobiliary center

Surgical approach and geriatric evaluation for elderly patients with colorectal cancer

Open versus minimally invasive surgery for rectal cancer: a single-center cohort study on 237 consecutive patients

Short-term outcomes after duodenal surgery for mesenchymal tumors: a retrospective analysis from a single tertiary referral center